These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33901574)

  • 1. Rationale and design of a randomized factorial clinical trial of pharmacogenetic and adherence optimization strategies to promote tobacco cessation among persons with HIV.
    Quinn MH; Bauer AM; Fox EN; Hatzell J; Randle T; Purnell J; Rogers T; Stevens N; Leone F; Achenbach C; Wileyto EP; Josephson S; Gollan J; Ashare R; Hitsman B; Schnoll R; Gross R
    Contemp Clin Trials; 2021 Nov; 110():106410. PubMed ID: 33901574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCT.
    Wells QS; Freiberg MS; Greevy RA; Tyndale RF; Kundu S; Duncan MS; King S; Abney L; Scoville E; Beaulieu DB; Gatskie V; Tindle HA
    Nicotine Tob Res; 2018 Nov; 20(12):1489-1496. PubMed ID: 29059367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and rate of nicotine metabolism are associated with response to treatment with varenicline among smokers with HIV.
    Bauer AM; Hosie Quinn M; Lubitz SF; Flitter A; Ashare RL; Leone FT; Gross R; Hitsman B; Schnoll R
    Addict Behav; 2021 Jan; 112():106638. PubMed ID: 32911350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes.
    Peng AR; Schnoll R; Hawk LW; Cinciripini P; George TP; Lerman C; Tyndale RF
    Drug Alcohol Depend; 2018 Sep; 190():72-81. PubMed ID: 29986268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
    Lerman C; Schnoll RA; Hawk LW; Cinciripini P; George TP; Wileyto EP; Swan GE; Benowitz NL; Heitjan DF; Tyndale RF;
    Lancet Respir Med; 2015 Feb; 3(2):131-138. PubMed ID: 25588294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
    Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
    Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine metabolite ratio and smoking outcomes using nicotine replacement therapy and varenicline among smokers with and without psychiatric illness.
    Clyde M; Pipe A; Els C; Reid R; Fu A; Clark A; Tulloch H
    J Psychopharmacol; 2018 Sep; 32(9):979-985. PubMed ID: 29788791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
    McCarthy DE; Versella MV
    Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study.
    Tseng TY; Krebs P; Schoenthaler A; Wong S; Sherman S; Gonzalez M; Urbina A; Cleland CM; Shelley D
    AIDS Behav; 2017 Jul; 21(7):1964-1974. PubMed ID: 27605365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on abstinence of nicotine patch treatment before quitting smoking: parallel, two arm, pragmatic randomised trial.
    Preloading Investigators
    BMJ; 2018 Jun; 361():k2164. PubMed ID: 29899061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial.
    Zawertailo L; Hendershot CS; Tyndale RF; Le Foll B; Samokhvalov AV; Thorpe KE; Pipe A; Reid RD; Selby P
    Trials; 2020 Jun; 21(1):592. PubMed ID: 32600406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
    Scoville EA; Tindle HA; Wells QS; Peyton SC; Gurwara S; Pointer SO; Horst SN; Schwartz DA; Adams DW; Freiberg MS; Gatskie V; King S; Abney LR; Beaulieu DB
    PLoS One; 2020; 15(3):e0230656. PubMed ID: 32214373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.